华北制药：下属公司华胜公司收到硫酸多黏菌素B化学原料药CEP证书

Core Viewpoint - Huabei Pharmaceutical (600812.SH) announced that its wholly-owned subsidiary, Huasheng Company, received the European Pharmacopoeia suitability certificate for Sulbactam Polymyxin B chemical raw material, indicating recognition of the product's quality by the EU market and allowing sales in Europe [1] Group 1 - The certificate signifies that Huasheng Company is the third domestic manufacturer to obtain the CEP certificate for Sulbactam Polymyxin B, highlighting its competitive position in the market [1] - The total R&D expenditure for the drug has reached 10.99 million yuan, reflecting the company's investment in developing this product [1]